TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 6 | 8 | 17 | 32 | 19 | 94 | 29 |
| P | %wins | 100 | 100 | 100 | 50 | 50 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/15/14 16:53 | 4/15/14 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Rusche James R | MA | O | SVP | P.d | 76 | 3.05 | 9 | 25 | 20 | 151 | D | 123 | 61 | 31 | 11 | -10 | 1 | 4 | -4 | 7 | 12 | 26 | 66 | 51 | 129 |
3/31/11 17:35 | 3/30/11 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Rusche James R | MA | O | SVP | P.d | 13 | 2.66 | 1 | 5 | New | 5 | D | -23 | -9 | 12 | -20 | -23 | 6 | -1 | -1 | 4 | 4 | 7 | -3 | -14 | 58 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |